136 related articles for article (PubMed ID: 9306041)
1. Glutamic acid decarboxylase antibodies in non-insulin-dependent diabetes patients with secondary sulfonylurea failure in Thailand.
Rattarasarn C; Aguilar Diosdado M; Soonthornpun S
Diabetes Res Clin Pract; 1997 Sep; 37(3):193-7. PubMed ID: 9306041
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic significance of antibodies to glutamic acid decarboxylase in Japanese diabetic patients with secondary oral hypoglycemic agents failure.
Fukui M; Nakano K; Maruya E; Saji H; Ohta K; Ohta M; Obayashi H; Mori H; Kajiyama S; Wada S; Shigeta H; Kitagawa Y; Nakamura N; Kondo M
Clin Immunol Immunopathol; 1997 Nov; 85(2):182-6. PubMed ID: 9344701
[TBL] [Abstract][Full Text] [Related]
3. Clinical characteristics of patients with the initial diagnosis of NIDDM with positivity for antibodies to glutamic acid decarboxylase.
Inukai T; Fujiwara Y; Tayama K; Aso Y; Ogino K; Takemura Y
Exp Clin Endocrinol Diabetes; 1997; 105(6):327-30. PubMed ID: 9439927
[TBL] [Abstract][Full Text] [Related]
4. Clinical evaluation of non-insulin-dependent diabetes mellitus patients with autoantibodies to glutamic acid decarboxylase.
Abiru N; Takino H; Yano M; Kawasaki E; Yamasaki H; Yamaguchi Y; Akazawa S; Nagataki S
J Autoimmun; 1996 Oct; 9(5):683-8. PubMed ID: 8933285
[TBL] [Abstract][Full Text] [Related]
5. Small doses of subcutaneous insulin as a strategy for preventing slowly progressive beta-cell failure in islet cell antibody-positive patients with clinical features of NIDDM.
Kobayashi T; Nakanishi K; Murase T; Kosaka K
Diabetes; 1996 May; 45(5):622-6. PubMed ID: 8621013
[TBL] [Abstract][Full Text] [Related]
6. Antibodies to glutamic acid decarboxylase in Japanese diabetic patients with secondary failure of oral hypoglycaemic therapy.
Fukui M; Nakano K; Shigeta H; Yoshimori K; Fujii M; Kitagawa Y; Mori H; Kajiyama S; Nakamura N; Abe N; Obayashi H; Fukui I; Ohta K; Ohta M; Kondo M
Diabet Med; 1997 Feb; 14(2):148-52. PubMed ID: 9047093
[TBL] [Abstract][Full Text] [Related]
7. Thyroid autoantibodies in Thai type 1 diabetic patients: clinical significance and their relationship with glutamic acid decarboxylase antibodies.
Rattarasarn C; Diosdado MA; Ortego J; Leelawattana R; Soonthornpun S; Setasuban W; Jaruratanasirikul S; Patarakijvanich N
Diabetes Res Clin Pract; 2000 Aug; 49(2-3):107-11. PubMed ID: 10963821
[TBL] [Abstract][Full Text] [Related]
8. GAD antibodies in NIDDM. Ten-year follow-up from the diagnosis.
Niskanen LK; Tuomi T; Karjalainen J; Groop LC; Uusitupa MI
Diabetes Care; 1995 Dec; 18(12):1557-65. PubMed ID: 8722051
[TBL] [Abstract][Full Text] [Related]
9. [Glutamic acid decarboxylase autoantibodies (antiGAD-Ab) in patients with non-insulin dependent diabetes mellitus (NIDDM)].
Martinka E; Straková J; Ocenásová A; Pullmannová D; Petrisková J; Mácková N; Sutarík L; Galajda P; Baláz D; Kerný J; Vladár L; Mokán M
Vnitr Lek; 1998 Jan; 44(1):17-22. PubMed ID: 9750478
[TBL] [Abstract][Full Text] [Related]
10. Distribution of autoantibodies to glutamic acid decarboxylase across the spectrum of diabetes mellitus seen in South Africa.
Panz VR; Kalk WJ; Zouvanis M; Joffe BI
Diabet Med; 2000 Jul; 17(7):524-7. PubMed ID: 10972582
[TBL] [Abstract][Full Text] [Related]
11. Antibodies to GAD in Japanese patients classified as Type 2 diabetes at diagnosis. High titre of GAD Ab is a predictive marker for early insulin treatment--report of west Japan (Kyushu, Yamaguchi, Osaka) study for GAD Ab(+) diabetes.
Takino H; Yamasaki H; Abiru N; Sera Y; Abe T; Kawasaki E; Yamaguchi Y; Eguchi K; Kanazawa Y; Nagataki S
Diabet Med; 2002 Sep; 19(9):730-4. PubMed ID: 12207808
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic role of antibodies to glutamic acid decarboxylase in latent autoimmune diabetes mellitus in adults.
Zhou Z; Ouyang L; Peng J; Yang W; Wang J; Zhu X; Wu H; Dyrberg T
Chin Med J (Engl); 1999 Jun; 112(6):554-7. PubMed ID: 11601338
[TBL] [Abstract][Full Text] [Related]
13. Latent autoimmune diabetes mellitus in adults (LADA): the role of antibodies to glutamic acid decarboxylase in diagnosis and prediction of insulin dependency.
Zimmet PZ; Tuomi T; Mackay IR; Rowley MJ; Knowles W; Cohen M; Lang DA
Diabet Med; 1994 Apr; 11(3):299-303. PubMed ID: 8033530
[TBL] [Abstract][Full Text] [Related]
14. Optimal cutoff point of glutamate decarboxylase antibody titers in differentiating two subtypes of adult-onset latent autoimmune diabetes.
Li X; Zhou ZG; Huang G; Yan X; Yang L; Chen XY; Wang JP
Ann N Y Acad Sci; 2004 Dec; 1037():122-6. PubMed ID: 15699504
[TBL] [Abstract][Full Text] [Related]
15. [Glutamic acid decarboxylase and tyrosine phosphatase-like IA-2 antibodies for diabetes classification in unselected diabetic patients].
Reinsch B; Zimmy S; Schatz H; Pfohl M
Med Klin (Munich); 2003 Feb; 98(2):67-71. PubMed ID: 12601530
[TBL] [Abstract][Full Text] [Related]
16. Seroconversion of glutamic acid decarboxylase antibodies in a patient initially diagnosed as having type 2 diabetes mellitus.
Nagai T; Imamura M; Mori M
Intern Med; 2005 Apr; 44(4):299-302. PubMed ID: 15897639
[TBL] [Abstract][Full Text] [Related]
17. Interventions for latent autoimmune diabetes (LADA) in adults.
Brophy S; Brunt H; Davies H; Mannan S; Williams R
Cochrane Database Syst Rev; 2007 Jul; (3):CD006165. PubMed ID: 17636829
[TBL] [Abstract][Full Text] [Related]
18. Glutamic acid decarboxylase65 (GAD65) antibodies and insulin auto-antibodies in Japanese patients with non-insulin-dependent diabetes mellitus.
Maruyama T; Kasuga A; Ozawa Y; Nagata A; Abiko F; Suzuki Y; Saruta T
Endocr J; 1997 Feb; 44(1):43-51. PubMed ID: 9152613
[TBL] [Abstract][Full Text] [Related]
19. Clinical characteristics, and time course of pancreatic beta-cell function and glutamic acid decarboxylase antibodies in Thai patients with adult-onset Type 1 diabetes: distinction between patients of rapid- and slow-onset.
Rattarasarn C; Diosdado MA
Horm Metab Res; 1999 May; 31(5):311-6. PubMed ID: 10422726
[TBL] [Abstract][Full Text] [Related]
20. [Islet beta cell function in latent autoimmune diabetes in adults with islet cell antibodies].
Yang L; Zhou ZG; Huang G; Yan X
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Jun; 29(3):309-14. PubMed ID: 16136967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
